Precision therapy for epilepsy due to KCNT1 mutations: A randomized trial of oral quinidine
Saul A Mullen, Patrick W Carney, Annie Roten, Michael Ching, Paul A Lightfoot, Leonid Churilov, Umesh Nair, Melody Li, Samuel F Berkovic, Steven Petrou, Ingrid E Scheffer
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2018
Awarded by National Health and Medical Research Council Program Grant
The study was supported by a National Health and Medical Research Council Program Grant (10915693). Florey Institute of Neuroscience and Mental Health is supported by Victorian State government infrastructure funds.